Related Experiment Video

Updated: Dec 26, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K

Treatment of atrial fibrillation: a comprehensive review and practice guide

Jianhua Li1, Mei Gao2, Minwei Zhang1

  • 1Department of Critical Care Medicine, The First Affiliated Hospital of Xiamen University, Xiamen 361003, PR China.

Cardiovascular Journal of Africa
|March 19, 2020
PubMed

Insights

Atrial fibrillation (AF), a common heart rhythm disorder, presents significant health challenges. Recent advancements offer improved strategies for preventing and managing AF through various therapies.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia.
  • AF imposes a substantial global burden due to high morbidity, disability, and mortality rates.
  • Effective management of AF is a critical focus in cardiovascular medicine.

Purpose of the Study:

  • To provide an updated overview of current treatment options for atrial fibrillation.
  • To inform healthcare providers on the latest evidence-based strategies for AF management.
  • To enhance the care of patients diagnosed with atrial fibrillation.

Main Methods:

  • Review of current therapeutic modalities for atrial fibrillation.
  • Synthesis of recent advancements in medical technology and clinical evidence.
  • Analysis of established and emerging AF treatment protocols.

Main Results:

  • Current AF therapies encompass drug treatment, catheter ablation, cryoballoon ablation, left atrial appendage closure, and the maze procedure.
  • Evolving understanding of AF pathophysiology has led to improved prevention and control strategies.
  • Medical technology advancements are continuously refining AF treatment approaches.

Conclusions:

  • The landscape of atrial fibrillation treatment is dynamic, with ongoing innovation.
  • A comprehensive approach integrating various therapies is essential for optimal AF patient care.
  • Staying abreast of the latest evidence is crucial for delivering state-of-the-art care to AF patients.

Keywords:
atrial fibrillationcatheter ablationcryoballoon ablationdrug therapyleft atrial appendage closuremaze procedure

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.0K

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
329
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
363
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
220
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
222
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
172
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
268